Last updated: May 6, 2024
Sponsor: Erasme University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Blood Clots
Anesthesia
Treatment
Transfusion
Clinical Study ID
NCT06403163
STAR
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- all patients who have received an hemostasis product
Exclusion
Exclusion Criteria:
- patient who refused to consent to data analysis and study participation
Study Design
Total Participants: 50000
Treatment Group(s): 1
Primary Treatment: Transfusion
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
December 31, 2030
Study Description
Connect with a study center
Université libre de Bruxelles
Anderlecht, 1070
BelgiumActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.